Your browser doesn't support javascript.
loading
A phase I study of PF-04449913, an oral hedgehog inhibitor, in patients with advanced solid tumors.
Wagner, Andrew J; Messersmith, Wells A; Shaik, M Naveed; Li, Sherry; Zheng, Xianxian; McLachlan, Karen R; Cesari, Rossano; Courtney, Rachel; Levin, Wendy J; El-Khoueiry, Anthony B.
Afiliação
  • Wagner AJ; Dana-Farber Cancer Institute, Boston, Massachusetts. Andrew_Wagner@dfci.harvard.edu.
  • Messersmith WA; University of Colorado Cancer Center, Aurora, Colorado.
  • Shaik MN; Pfizer Oncology, La Jolla, California.
  • Li S; Pfizer China Research and Development Center, Shanghai, China.
  • Zheng X; Pfizer Oncology, La Jolla, California.
  • McLachlan KR; Pfizer Oncology, La Jolla, California.
  • Cesari R; Pfizer Oncology, Milan, Italy.
  • Courtney R; Pfizer Oncology, La Jolla, California.
  • Levin WJ; Pfizer Oncology, La Jolla, California.
  • El-Khoueiry AB; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California.
Clin Cancer Res ; 21(5): 1044-51, 2015 03 01.
Article em En | MEDLINE | ID: mdl-25388167

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Benzimidazóis / Proteínas Hedgehog / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Benzimidazóis / Proteínas Hedgehog / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article